Unknown

Dataset Information

0

Prognostic value of NT-proBNP in patients with severe COVID-19.


ABSTRACT:

Background

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. The cardiac injury is a common condition among the hospitalized patients with COVID-19. However, whether N terminal pro B type natriuretic peptide (NT-proBNP) predicted outcome of severe COVID-19 patients was unknown.

Methods

The study initially enrolled 102 patients with severe COVID-19 from a continuous sample. After screening out the ineligible cases, 54 patients were analyzed in this study. The primary outcome was in-hospital death defined as the case fatality rate. Research information and following-up data were obtained from their medical records.

Results

The best cut-off value of NT-proBNP for predicting in-hospital death was 88.64 pg/mL with the sensitivity for 100% and the specificity for 66.67%. Patients with high NT-proBNP values (> 88.64 pg/mL) had a significantly increased risk of death during the days of following-up compared with those with low values (≤88.64 pg/mL). After adjustment for potential risk factors, NT-proBNP was independently correlated with in-hospital death.

Conclusion

NT-proBNP might be an independent risk factor for in-hospital death in patients with severe COVID-19.

Trial registration

ClinicalTrials, NCT04292964. Registered 03 March 2020.

SUBMITTER: Gao L 

PROVIDER: S-EPMC7156898 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8013330 | biostudies-literature
| S-EPMC6913023 | biostudies-literature
| S-EPMC9319637 | biostudies-literature
| S-EPMC8266470 | biostudies-literature
| S-EPMC8426942 | biostudies-literature
| S-BSST416 | biostudies-other
2020-10-28 | GSE158127 | GEO
2022-09-22 | E-MTAB-12236 | biostudies-arrayexpress
| S-EPMC8063320 | biostudies-literature
| S-EPMC8318442 | biostudies-literature